Here, we characterize for the first time the longitudinal outcome of circulating fetuin-A concentrations in nonobese adolescents with PCOS and show that fetuin-A levels normalize after treatment with a low-dose combination of insulin sensitizers and an antiandrogen, but not after OC. This evidence concerns the gene INS and polycystic ovary syndrome.